pirifibrate
3
relevant articles (0 outcomes,
0 trials/studies)
found for this Bio-Agent
Also Known As:
(6-(hydroxymethyl)-2-pyridyl)methyl-2-(4-chlorophenoxy)-2-methyl-propionate hydrochloride; Bratenol; EL-466; Propanoic acid, 2-(4-chlorophenoxy)-2-methyl-, (6-(hydroxymethyl)-2-pyridinyl)methyl ester, hydrochloride
Bio-Agent Context: Research Results
Related Diseases
| 1. | Hyperlipoproteinemias
01/01/1981
- " A new drug, pirifibrate, was investigated in a multicenter study of 100 patients with type IIa, IIb, or IV hyperlipoproteinemia (HLP)" 01/01/1981
- " Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations." 01/01/1980
- " Pirifibrate was given to 53 patients with type IIa, IIb or IV hyperlipoproteinemia (HLP), and the results of the first three months of treatment were evaluated" 01/01/1980
- " Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV." 01/01/1980
- " Pirifibrate, a new hypolipemic substance, was studied in a multicenter trial for three months in 151 patients diagnosed as having type IIa, IIb or IV hyperlipoproteinemia (HLP)"
Order ALL the reference details at left...
|
|